Prostate cancer researchers develop personalized genetic test to predict recurrence risk
2014-11-13
(Press-News.org) (TORONTO, Canada - Nov. 13, 2014) - Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.
The findings are published online today in Lancet Oncology. Study co-leads Dr. Robert Bristow, a clinician-scientist at Princess Margaret Cancer Centre, and Dr. Paul Boutros, an investigator at the Ontario Institute for Cancer Research, report that the gene test provides a much-needed quick and accurate tool to determine with greater precision the men who will do well with local treatment only (surgery or radiation), and those who will need extra treatment (chemotherapy and hormone therapy) to ensure the cancer is completely eradicated. Dr. Bristow talks about the research at http://youtu.be/7dZyVm_y5WU
"Our findings set the stage to tackle the ongoing clinical problem of under-treating men with aggressive disease that will recur in 30% to 50% of patients due to hidden, microscopic disease that is already outside the prostate gland during initial treatment," says Dr. Bristow.
"This genetic test could increase cure rates in intermediate- to high-risk men by preventing progression to this metastatic spread of prostate cancer." The next step will be testing the gene signature on many more patients worldwide for three to five years to turn the test into one that is readily available in the clinic to guide personalized prostate cancer treatments.
The predictive test analyses biopsy tissue taken before treatment even starts to identify abnormal genetic characteristics (abnormal DNA) of the prostate cancer and its oxygen content. Low oxygen, or hypoxia, is an already known factor in the spread of prostate cancer. Together, this information can predict with almost 80% accuracy - and in about three days - those prostate cancer patients who are at greatest risk of their disease returning, the study shows.
"The clinical potential is enormous for thousands of patients," says Dr. Bristow. "This is personalized cancer medicine to the hilt - the ability to provide more targeted treatment to patients based on their unique cancer genetic fingerprint plus what's going on in the cancer cell's surrounding environment. We hope to improve cure rates by reducing the chances of the cancer recurring and prevent the cells from spreading."
The researchers developed the genetic test with two groups of patients. In the first group, the team analyzed DNA from initial diagnostic biopsies of 126 men who were treated with image-guided radiotherapy (IGRT) and followed for an average 7.8 years. In the second group, the team used the test on 150 men whose tumours were removed surgically (radical prostatectomy). The genetic test produced similar results in both groups and therefore can be used in patients who choose radiotherapy or surgery as their initial treatment.
The researchers further found that when testing tumours for hypoxia in the men treated with IGRT and the gene test, this combined information made the test even more accurate, says Dr. Bristow.
The study showed that the men with the best outcomes - lower than 7% recurrence of prostate cancer at five years - had low levels of genetic changes and low hypoxia. For men with high levels of genetic changes and high hypoxia, outcomes were worse - more than 50% of patients had recurrence and these are men who, in the future, could be offered intensified treatment as part of a personalized treatment plan.
INFORMATION:
Drs. Bristow and Boutros also co-lead the Canadian Prostate Cancer Genome Network (CPC-GENE) Sequencing Project. Dr. Bristow is a Professor in the Departments of Radiation Oncology and Medical Biophysics, University of Toronto, where Dr. Boutros is an Assistant Professor, Department of Medical Biophysics.
Funding was provided by Prostate Cancer Canada, The Movember Foundation, the Ontario Institute for Cancer Research, and The Princess Margaret Cancer Foundation. The study was conducted with assistance from the Wellcome Trust Clinical Research Facility, Addenbrooke's Clinical Research Centre, Cambridge, U.K.
About Princess Margaret Cancer Centre, University Health Network
The Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is a member of University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute. All are research hospitals affiliated with the University of Toronto. For more information, go to http://www.theprincessmargaret.ca or http://www.uhn.ca .
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-13
Rare mutations that shut down a single gene are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, according to new research from Washington University School of Medicine in St. Louis, the Broad Institute at Massachusetts Institute of Technology and Harvard, and other institutions.
The gene, called NPC1L1, is of interest because it is the target of the drug ezetimibe, often prescribed to lower cholesterol.
The study appears Nov. 12 in The New England Journal of Medicine.
Everyone inherits two copies of most genes -- one copy ...
2014-11-13
A study in which more than 43,000 children were evaluated for head trauma offers an unprecedented picture of how children most frequently suffer head injuries, report physicians at Washington University School of Medicine in St. Louis and the University of California, Davis, School of Medicine.
The findings also indicate how often such incidents result in significant brain injuries, computerized tomography (CT) scans to assess head injuries, and neurosurgery to treat them.
In children ages 12 and younger, falls were the most common cause of head injuries. In children ...
2014-11-13
Philadelphia, PA, November 12, 2014 - Critical care is defined by life-threatening conditions, which require close evaluation, monitoring, and treatment by appropriately trained health professionals. Cardiovascular care bears these same requirements. In fact, cardiovascular disease will soon surpass even human immunodeficiency virus (HIV) as the leading cause of mortality in Sub-Saharan Africa. In the latest issue of Global Heart, researchers discuss the challenges of delivering critical care in resource-limited countries.
According to Guest Editors Vanessa Kerry, MD, ...
2014-11-13
What time is it? The answer, no matter what your initial reference may be -- a wristwatch, a smartphone, or an alarm clock -- will always trace back to the atomic clock.
The international standard for time is set by atomic clocks -- room-sized apparatuses that keep time by measuring the natural vibration of atoms in a vacuum. The frequency of atomic vibrations determines the length of one second -- information that is beamed up to GPS satellites, which stream the data to ground receivers all over the world, synchronizing cellular and cable networks, power grids, and ...
2014-11-13
(Santa Barbara, California) -- The world is gaining weight and becoming less healthy, and global dietary choices are harming the environment.
Those are among the findings of a paper co-authored by David Tilman, a professor in the Bren School of Environmental Science & Management, and Michael Clark, a graduate student at the University of Minnesota, where Tilman also is a professor. In "Global Diets Link Environmental Sustainability and Human Health," published today in the journal Nature, the researchers find that rising incomes and urbanization around the world are ...
2014-11-12
MINNEAPOLIS - Taking vitamin B12 and folic acid supplements may not reduce the risk of memory and thinking problems after all, according to a new study published in the November 12, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the largest to date to test long-term use of supplements and thinking and memory skills.
The study involved people with high blood levels of homocysteine, an amino acid. High levels of homocysteine have been linked to memory loss and Alzheimer's disease.
"Since homocysteine ...
2014-11-12
A protein that may partly explain why human brains are larger than those of other animals has been identified by scientists from two stem-cell labs at UC San Francisco, in research published in the November 13, 2014 issue of Nature.
Key experiments by the UCSF researchers revealed that the protein, called PDGFD, is made in growing brains of humans, but not in mice, and appears necessary for normal proliferation of human brain stem cells growing in a lab dish.
The scientists made their discovery as part of research in which they identified genes that are activated to ...
2014-11-12
U.S. Army soldiers hospitalized with a psychiatric disorder have a significantly elevated suicide risk in the year following discharge from the hospital, according to research from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). The yearly suicide rate for this group, 263.9 per 100,000 soldiers, was far higher than the rate of 18.5 suicides per 100,000 in the Regular Army for the same study period, the study found.
The researchers looked at data from the 12 months following a hospital discharge for more than 40,000 anonymous, Regular Army ...
2014-11-12
It has long been known that patients recently discharged from psychiatric hospitalizations have a significantly elevated suicide risk. However, the rarity of suicide even in this high-risk segment of the population makes it impractical to justify providing intensive post-hospital suicide prevention programs to all recently discharged patients. Targeted programs for patients at especially high suicide risk would be more feasible, but it is difficult for clinicians to predict with good accuracy which patients are at high risk for suicide.
A new report published online today ...
2014-11-12
Nearly a quarter of all patients who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention, according to a report published online by JAMA Surgery.
Completely removing breast cancer is seen as the best way to reduce recurrence and improve survival. A lack of consensus on an adequate margin width has led to variable rates of reexcision and, as a result, patients undergo repeat or additional surgeries, according to background information provided in the study.
Lee G. Wilke, M.D., of the University of Wisconsin School ...
LAST 30 PRESS RELEASES:
[Press-News.org] Prostate cancer researchers develop personalized genetic test to predict recurrence risk
